Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2023		205,771
Beginning balance at Dec. 31, 2023	$ (455,528)	$ 2,058	$ 1,222,236	$ 1,337	$ (1,681,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(35,379)				(35,379)
Other comprehensive income (loss)	(566)			(566)
Exercise of stock options, net (in shares)		176
Exercise of stock options, net	552	$ 2	550
Vesting of restricted stock units (in shares)		155
Vesting of restricted stock units	0	$ 1	(1)
Shares withheld for taxes for vesting of restricted stock units (in shares)		(8)
Shares withheld for taxes for vesting of restricted stock units	(38)		(38)
Employee stock purchase plan sales, net (in shares)		251
Employee stock purchase plan sales	1,129	$ 2	1,127
Issuance of shares to directors in lieu of cash retainer (in shares)		2
Issuance of shares to directors in lieu of cash retainer	11		11
Stock-based compensation expense	13,652		13,652
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2024		206,347
Ending balance at Mar. 31, 2024	(476,167)	$ 2,063	1,237,537	771	(1,716,538)
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2023		205,771
Beginning balance at Dec. 31, 2023	(455,528)	$ 2,058	1,222,236	1,337	(1,681,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(48,053)
Other comprehensive income (loss)	(780)
Common stock, shares outstanding, ending balance (in shares) at Jun. 30, 2024		206,629
Ending balance at Jun. 30, 2024	(475,606)	$ 2,066	1,250,983	557	(1,729,212)
Common stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2024		206,347
Beginning balance at Mar. 31, 2024	(476,167)	$ 2,063	1,237,537	771	(1,716,538)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(12,674)				(12,674)
Other comprehensive income (loss)	(214)			(214)
Exercise of stock options, net (in shares)		80
Exercise of stock options, net	264	$ 1	263
Vesting of restricted stock units (in shares)		200
Vesting of restricted stock units	0	$ 2	(2)
Issuance of shares to directors in lieu of cash retainer (in shares)		2
Issuance of shares to directors in lieu of cash retainer	12		12
Stock-based compensation expense	13,173		13,173
Common stock, shares outstanding, ending balance (in shares) at Jun. 30, 2024		206,629
Ending balance at Jun. 30, 2024	$ (475,606)	$ 2,066	1,250,983	557	(1,729,212)
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2024	208,543	208,543
Beginning balance at Dec. 31, 2024	$ (475,934)	$ 2,085	1,291,100	921	(1,770,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	32				32
Other comprehensive income (loss)	211			211
Exercise of stock options, net (in shares)		286
Exercise of stock options, net	1,229	$ 3	1,226
Vesting of restricted stock units (in shares)		184
Vesting of restricted stock units	0	$ 2	(2)
Shares withheld for taxes for vesting of restricted stock units (in shares)		(8)
Shares withheld for taxes for vesting of restricted stock units	(56)		(56)
Employee stock purchase plan sales, net (in shares)		202
Employee stock purchase plan sales	1,217	$ 2	1,215
Issuance of shares to directors in lieu of cash retainer (in shares)		1
Issuance of shares to directors in lieu of cash retainer	6		6
Stock-based compensation expense	21,368		21,368
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2025		209,208
Ending balance at Mar. 31, 2025	$ (451,927)	$ 2,092	1,314,857	1,132	(1,770,008)
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2024	208,543	208,543
Beginning balance at Dec. 31, 2024	$ (475,934)	$ 2,085	1,291,100	921	(1,770,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,117
Other comprehensive income (loss)	$ 725
Common stock, shares outstanding, ending balance (in shares) at Jun. 30, 2025	209,905	209,905
Ending balance at Jun. 30, 2025	$ (421,594)	$ 2,099	1,339,584	1,646	(1,764,923)
Common stock, shares outstanding, beginning balance (in shares) at Mar. 31, 2025		209,208
Beginning balance at Mar. 31, 2025	(451,927)	$ 2,092	1,314,857	1,132	(1,770,008)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,085				5,085
Other comprehensive income (loss)	514			514
Exercise of stock options, net (in shares)		560
Exercise of stock options, net	3,421	$ 6	3,415
Vesting of restricted stock units (in shares)		136
Vesting of restricted stock units	0	$ 1	(1)
Issuance of shares to directors in lieu of cash retainer (in shares)		1
Issuance of shares to directors in lieu of cash retainer	9		9
Stock-based compensation expense	$ 21,304		21,304
Common stock, shares outstanding, ending balance (in shares) at Jun. 30, 2025	209,905	209,905
Ending balance at Jun. 30, 2025	$ (421,594)	$ 2,099	$ 1,339,584	$ 1,646	$ (1,764,923)